Alpha Teknova, Inc. (TKNO)
NASDAQ: TKNO · Real-Time Price · USD
7.63
-0.18 (-2.30%)
At close: Nov 20, 2026, 4:00 PM EST
7.67
+0.04 (0.52%)
After-hours: Nov 20, 2026, 7:31 PM EST
Alpha Teknova Market Cap
Alpha Teknova has a market cap or net worth of $479.95 million as of November 20, 2026. It is the 13,975th most valuable company in the world and the 2,663rd biggest in the United States. Its market cap has increased by 102.85% in one year.
Market Cap
479.95M
Enterprise Value
490.38M
1-Year Change
102.85%
Global Rank
Country Rank
#2,663 United States
Category
ChartMarket Cap Chart
Since the IPO on June 25, 2021, Alpha Teknova's market cap has increased from $433.79M to $479.95M, an increase of 10.64%. That is a compound annual growth rate of 1.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 479.95M | 135.95% |
| Dec 31, 2025 | 203.41M | -54.30% |
| Dec 31, 2024 | 445.12M | 193.01% |
| Dec 29, 2023 | 151.91M | -4.25% |
| Dec 30, 2022 | 158.66M | -72.34% |
| Dec 31, 2021 | 573.68M | 32.25% |
| Jun 25, 2021 (IPO) | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cronos Group | 1.14B |
| Collegium Pharmaceutical | 784.34M |
| Ironwood Pharmaceuticals | 778.09M |
| Evotec SE | 528.12M |
| Evolus | 469.28M |
| Aquestive Therapeutics | 466.93M |
| Kamada | 448.85M |
| Tilray Brands | 315.32M |